TRY AIM: Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial

Sponsor
Penn State University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05794178
Collaborator
(none)
360
3
43

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to test a precision (person-specific and context-sensitive) messaging algorithm for increasing physical activity and slowing weight gain in insufficiently-active young adults. The main questions it aims to answer are:

  • Does physical activity increase more when text messages are sent based on a precision rule for selecting and timing messages compared to when the same message content is selected and sent at random or not at all?

  • Do biological or social characteristics of young adults make them more likely to respond positively to the precision messaging intervention than either of the other two interventions?

Participants will be provided with education about health-enhancing physical activity and given an activity tracker to wear for 12 months. They will then be randomly assigned to one of three groups. Participants in one group (Precision AIM) will receive up to 4 messages/day selected and timed based on a person-specific algorithm that forecasts possible message effects periodically throughout the day. Messages will be drawn from one of three content libraries: move more, sit less, or inspirational quotes. Participants in a second group (Random AIM) will receive 4 messages/day selected at random from the same three content libraries and delivered at random times within their availability window. Participants in the third group (No AIM) will receive not motivational messages but will randomly assigned to the Random AIM group will receive up to 4 messages/day drawn at random from three content libraries at randomly-selected times. Step counts and weight will be assessed at baseline, and at 3 months, 6 months, 12 months, and 18 months. Researchers will compare Precision AIM, Random AIM and No AIM groups to see if physical activity increased more and weight gain was slower in Precision AIM than Random AIM or No AIM after 3, 6, and 12 months of intervention, and 6 months after the intervention is complete (18 months).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Education
  • Behavioral: Activity tracker
  • Behavioral: Text messaging (random timing and selection)
  • Behavioral: Text messaging (precision dosing)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
360 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Testing Responses of Young Adults to Intervention Messages (TRY AIM) for Promoting Physical Activity Trial
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
May 1, 2026
Anticipated Study Completion Date :
Nov 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Precision AIM

Education + activity monitor + up to 4 text messages/day, each drawn from one of 3 content libraries and timed based on a person- and context-specific algorithm that will be updated monthly based on incoming data (within a participant-defined availability window)

Behavioral: Education
Education about health benefits of physical activity, 2018 US Physical Activity Guidelines, assigned goals tailored to baseline step counts, and worksheet to develop action and coping plans (three of each)

Behavioral: Activity tracker
Fitbit activity tracker and mobile app to provide ad libitum behavioral feedback and self-regulatory support

Behavioral: Text messaging (precision dosing)
Up to four text messages/day within a participant's availability window, timed and selected from one of three content libraries (move more, sit less, inspirational quotes) based on a person-specific dynamic model and contextual data

Active Comparator: Random AIM

Education + activity monitor + up to 4 text messages/day, each drawn from one of 3 content libraries and timed at random (within a participant-defined availability window).

Behavioral: Education
Education about health benefits of physical activity, 2018 US Physical Activity Guidelines, assigned goals tailored to baseline step counts, and worksheet to develop action and coping plans (three of each)

Behavioral: Activity tracker
Fitbit activity tracker and mobile app to provide ad libitum behavioral feedback and self-regulatory support

Behavioral: Text messaging (random timing and selection)
Four text messages/day at random times within a participant's availability window and drawn at random from one of three content libraries (move more [40%], sit less [40%], inspirational quotes [20%])

Active Comparator: No AIM

Education + activity monitor

Behavioral: Education
Education about health benefits of physical activity, 2018 US Physical Activity Guidelines, assigned goals tailored to baseline step counts, and worksheet to develop action and coping plans (three of each)

Behavioral: Activity tracker
Fitbit activity tracker and mobile app to provide ad libitum behavioral feedback and self-regulatory support

Outcome Measures

Primary Outcome Measures

  1. Average daily step counts (6 months) [Change from baseline to 6 months]

    Average daily step counts recorded by Actigraph accelerometer over a 7-day monitoring period

Secondary Outcome Measures

  1. Average daily step counts (12 months) [Change from baseline to 12 months]

    Average daily step counts recorded by Actigraph accelerometer over a 7-day monitoring period

  2. Average daily step counts (18 months) [Change from 12 months to 18 months]

    Average daily step counts recorded by Actigraph accelerometer over a 7-day monitoring period

  3. Weight (6 months) [Change from baseline to 6 months]

    Weight (kg) measured by BodyTrace scale

  4. Weight (12 months) [Change from baseline to 12 months]

    Weight (kg) measured by BodyTrace scale

  5. Weight (18 months) [Change from 12 months to 18 months]

    Weight (kg) measured by BodyTrace scale

  6. Moderate-to-vigorous intensity physical activity duration (6 months) [Change from baseline to 6 months]

    Average duration of daily moderate (or higher) physical activity recorded by Actigraph accelerometer over a 7-day monitoring period

  7. Moderate-to-vigorous intensity physical activity duration (12 months) [Change from baseline to 12 months]

    Average duration of daily moderate (or higher) physical activity recorded by Actigraph accelerometer over a 7-day monitoring period

  8. Moderate-to-vigorous intensity physical activity duration (18 months) [Change from 12 months to 18 months]

    Average duration of daily moderate (or higher) physical activity recorded by Actigraph accelerometer over a 7-day monitoring period

  9. Light intensity physical activity duration (6 months) [Change from baseline to 6 months]

    Average duration of daily light-intensity physical activity recorded by Actigraph accelerometer over a 7-day monitoring period

  10. Light intensity physical activity duration (12 months) [Change from baseline to 12 months]

    Average duration of daily light-intensity physical activity recorded by Actigraph accelerometer over a 7-day monitoring period

  11. Light intensity physical activity duration (18 months) [Change from 12 months to 18 months]

    Average duration of daily light-intensity physical activity recorded by Actigraph accelerometer over a 7-day monitoring period

  12. Sedentary behavior duration (6 months) [Change from baseline to 6 months]

    Average duration of daily sedentary behavior physical activity recorded by Actigraph accelerometer over a 7-day monitoring period

  13. Sedentary behavior duration (12 months) [Change from baseline to 12 months]

    Average duration of daily sedentary behavior recorded by Actigraph accelerometer over a 7-day monitoring period

  14. Sedentary behavior duration (18 months) [Change from 12 months to 18 months]

    Average duration of daily sedentary behavior recorded by Actigraph accelerometer over a 7-day monitoring period

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 29 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • own an iPhone or Android smartphone that they would be willing to download the Fitbit app onto and sync with a Fitbit tracker and a custom, AIM app

  • willing to wear a Fitbit tracker almost continually (23.5 hours/day) for a 12- month period of time

  • free of visual impairment that would interfere with the receipt of text messages on their phone

  • capable of reading, speaking and understanding English and of giving informed consent

  • willing to complete a full 18-month study protocol

Exclusion Criteria:
  • self-report sufficient aerobic activity to meet 2018 Physical Activity Guidelines for American adults

  • research-grade accelerometer records sufficient aerobic physical activity to meet 2018 Physical Activity Guidelines for American adults

  • living outside the continental US

  • one or more contraindications to physical activity

  • require an assistive device for mobility or have any other condition that may limit or prevent participation in moderate-intensity physical activity

  • pregnant or planning to become pregnant within the next 12 months

  • prior diagnosis of cancer, cardiovascular disease, diabetes or metabolic syndrome

  • concurrent participation in another research study involving physical activity or weight loss

  • planning to have surgery or relocate outside the continental US within the next year.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Penn State University

Investigators

  • Principal Investigator: David E Conroy, PhD, The Pennsylvania State University
  • Principal Investigator: Constantino M Lagoa, PhD, The Pennsylvania State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
David E Conroy, Professor, Penn State University
ClinicalTrials.gov Identifier:
NCT05794178
Other Study ID Numbers:
  • STUDY00019311
First Posted:
Apr 3, 2023
Last Update Posted:
Apr 3, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 3, 2023